Drug launches, new permissions should be made public, say pharma MNCs

In a recent meeting held by the drug controller on global clinical trials, the OPPI sought from the government a notification system through the drug regulatory authority's digital portal-SUGAM. It has asked for linking of the SUGAM Portal at Centre and state levels and, then, making public the non-commercial information in respect of the filed/pending applications and the approvals granted, it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bX5nL0t
via IFTTT